IP Verse

Animal Models And Therapeutic Molecules

Patent No. EP2792236 (titled "Animal Models And Therapeutic Molecules") was filed by Kymab on Jul 7, 2010. The application was issued on Mar 22, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSAug 14, 2018J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2792236

KYMAB
Application Number
EP14176740A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
Feb 17, 2023
Publication Date
Mar 22, 2023
External Links
Slate, Register , Google Patents